NorthSea Therapeutics
NorthSea Therapeutics develops therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.
- CEO Rob de Ree
- Industry Biotech
Worked on by
Sander Slootweg, MSc
Managing Partner
Sander is Managing Partner and co-founded ABN AMRO Capital Life Sciences in 2000 and Forbion Capital Partners in 2006.
Read more
Marco Boorsma, PhD
General Partner
Marco is General Partner at Forbion and joined the team in 2007.
Read more